Chimeric NK-receptor–bearing T cells mediate antitumor immunotherapy
Open Access
- 1 September 2005
- journal article
- Published by American Society of Hematology in Blood
- Vol. 106 (5), 1544-1551
- https://doi.org/10.1182/blood-2004-11-4365
Abstract
NKG2D is an activating cell-surface receptor expressed on natural killer (NK) cells and some T-cell subsets. Its ligands are primarily expressed on tumor cells. The aim of this study was to determine whether chimeric NK-receptor—bearing T cells would directly kill tumor cells and lead to induction of host immunity against tumors. Chimeric NK receptors were produced by linking NKG2D or DNAX activating protein of 10 kDa (Dap10) to the cytoplasmic portion of the CD3ζ chain. Our results showed that chimeric (ch) NKG2D-bearing T cells responded to NKG2D-ligand–bearing tumor cells (RMA/Rae-1β, EG7) but not to wild-type tumor cells (RMA). This response was dependent upon ligand expression on the target cells but not on expression of major histocompatibility complex (MHC) molecules, and the response could be blocked by anti-NKG2D antibodies. These T cells produced large amounts of T-helper 1 (Th1) cytokines and proinflammatory chemokines and killed ligand–expressing tumor cells. Adoptive transfer of chNKG2D-bearing T cells inhibited RMA/Rae-1β tumor growth in vivo. Moreover, mice that had remained tumor-free were resistant to subsequent challenge with the wild-type RMA tumor cells, suggesting the generation of immunity against other tumor antigens. Taken together, our findings indicate that modification of T cells with chimeric NKG2D receptors represents a promising approach for immunotherapy against cancer.Keywords
This publication has 50 references indexed in Scilit:
- Transgenic TCR expression: comparison of single chain with full-length receptor constructs for T-cell functionCancer Gene Therapy, 2004
- Roles of the NKG2D immunoreceptor and its ligandsNature Reviews Immunology, 2003
- Functional significance of the perforin/granzyme cell death pathwayNature Reviews Immunology, 2002
- Interleukin (IL)-15 and IL-7 Jointly Regulate Homeostatic Proliferation of Memory Phenotype CD8+ Cells but Are Not Required for Memory Phenotype CD4+ CellsThe Journal of Experimental Medicine, 2002
- Natural killer cells, viruses and cancerNature Reviews Immunology, 2001
- A Fas-based suicide switch in human T cells for the treatment of graft-versus-host diseaseBlood, 2001
- The Role of Chemokine Receptors in Primary, Effector, and Memory Immune ResponsesAnnual Review of Immunology, 2000
- HSV-TK Gene Transfer into Donor Lymphocytes for Control of Allogeneic Graft-Versus-LeukemiaScience, 1997
- Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategyNature, 1986
- Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism.The Journal of Experimental Medicine, 1985